CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,113 | $109.58 | $232K | 138,820 |
| 2024-10-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −239 | $110.35 | $26K | 138,581 |
| 2024-10-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −356 | $107.50 | $38K | 141,774 |
| 2024-10-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −807 | $108.75 | $88K | 140,967 |
| 2024-10-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,849 | $109.43 | $202K | 139,118 |
| 2024-10-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −537 | $110.20 | $59K | 138,581 |
| 2024-10-07 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +5,000 | $21.41 | $107K | 33,623 |
| 2024-10-07 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −476 | $107.51 | $51K | 33,147 |
| 2024-10-07 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −996 | $108.69 | $108K | 32,151 |
| 2024-10-07 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −3,147 | $109.55 | $345K | 29,004 |
| 2024-10-07 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −314 | $110.51 | $35K | 28,690 |
| 2024-10-07 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −67 | $111.68 | $7K | 28,623 |
| 2024-10-07 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 169,497 | ||
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −3,624 | $113.38 | $411K | 461,595 |
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −7,088 | $114.27 | $810K | 454,507 |
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −4,288 | $114.99 | $493K | 450,219 |
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +20,000 | $5.35 | $107K | 470,219 |
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −4,305 | $113.35 | $488K | 465,914 |
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −9,429 | $114.20 | $1.1M | 456,485 |
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −6,266 | $114.93 | $720K | 450,219 |
Page 20 of 39 · 764 trades